(19 May 2021) Meplazumab- could accelerate the recovery of patients with a favorable safety profile
Safety and efficacy of meplazumab in healthy volunteers and COVID-19 patients: a randomized phase 1 and an exploratory phase 2 trial https://doi.org/10.1038/s41392-021-00603-6 NCT04369586, NCT04275245- In phase 1 study, 59 subjects were enrolled and assigned to eight cohorts, and no serious… Continue reading "(19 May 2021) Meplazumab- could accelerate the recovery of patients with a favorable safety profile"